Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Deloitte
Accenture
AstraZeneca
Chubb
Mallinckrodt
Farmers Insurance
Argus Health
Covington

Generated: February 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NICODERM CQ

« Back to Dashboard

Clinical Trials for Nicoderm Cq

Trial ID Title Status Sponsor Phase Summary
NCT00086411 Comparing Smoking Treatment Programs for Lighter Smokers - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.
NCT00086411 Comparing Smoking Treatment Programs for Lighter Smokers - 1 Completed Peter Gariti Phase 2 The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two levels of counseling. It was hypothesized that the higher level of counseling would have the highest rates of treatment completion and highest rates of abstinence.
NCT00139516 Chinese Community Smoking Cessation Project Completed National Heart, Lung, and Blood Institute (NHLBI) N/A The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00139516 Chinese Community Smoking Cessation Project Completed University of California, San Francisco N/A The study has two objectives/aims: Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese adults with and without diseases); and Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking process) that are associated with smoking cessation at 6 and 12 months
NCT00158171 Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
NCT00218296 Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Nicoderm Cq

Condition Name

Condition Name for Nicoderm Cq
Intervention Trials
Nicotine Dependence 10
Smoking Cessation 8
Tobacco Use Disorder 6
Smoking 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Nicoderm Cq
Intervention Trials
Tobacco Use Disorder 16
Cardiovascular Diseases 2
Heart Diseases 2
Coronary Artery Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Nicoderm Cq

Trials by Country

Trials by Country for Nicoderm Cq
Location Trials
United States 19
Canada 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Nicoderm Cq
Location Trials
North Carolina 12
Minnesota 2
Maryland 1
Wisconsin 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Nicoderm Cq

Clinical Trial Phase

Clinical Trial Phase for Nicoderm Cq
Clinical Trial Phase Trials
Phase 4 3
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Nicoderm Cq
Clinical Trial Phase Trials
Completed 16
Not yet recruiting 5
Recruiting 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Nicoderm Cq

Sponsor Name

Sponsor Name for Nicoderm Cq
Sponsor Trials
National Institute on Drug Abuse (NIDA) 11
Duke University 9
Centre for Addiction and Mental Health 5
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Nicoderm Cq
Sponsor Trials
Other 33
NIH 13
Industry 7
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cipla
Healthtrust
Teva
Deloitte
Mallinckrodt
Fuji
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.